EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation

• Main Authors: Michela Campolo (Author), Sarah Adriana Scuderi (Author), Alessia Filippone (Author), Valentina Bova (Author), Sofia Paola Lombardo (Author), Lorenzo Colarossi (Author), Serena Sava (Author), Anna Paola Capra (Author), Federica De Gaetano (Author), Marco Portelli (Author), Angela Militi (Author), Emanuela Esposito (Author), Irene Paterniti (Author)
• Format: Book
• Published: MDPI AG, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Oral squamous cell carcinoma (OSCC) is one of the most common human malignancies worldwide. The molecular mechanisms of OSCC pathogenesis are still unknown; however, in recent years, several reports have focused on the role of enhancer of zeste homolog 2 (EZH2) in OSCC. Therefore, in this study we a...